论文部分内容阅读
目的分析阿奇霉素联合沐舒坦治疗小儿支原体肺炎的临床疗效。方法选取2012年至2014年8月睢县人民医院接受治疗的小儿支原体肺炎70例患者,将其随机分为对照组和试验组,每组35例,对照组给予阿奇霉素治疗,试验组联合沐舒坦治疗,比较两组患儿的治愈率和临床症状的改善情况等。结果两组治疗5~10 d后,对照组总有效率明显低于试验组,咳嗽消失时间、肺部啰音消失时间、呼吸急促缓解时间明显长于试验组,差异有统计学意义(P<0.05)。结论阿奇霉素联合沐舒坦治疗小儿支原体肺炎病情明显好转,值得广泛推广应用。
Objective To analyze the clinical efficacy of azithromycin and mucosolvan in the treatment of children with mycoplasma pneumonia. Methods Seventy patients with Mycoplasma pneumoniae pneumonia in Yixian People’s Hospital from 2012 to August 2014 were randomly divided into control group and experimental group, with 35 cases in each group. The control group was treated with azithromycin. The experimental group was treated with mucosolvan Treatment, the cure rate and the improvement of clinical symptoms in both groups were compared. Results After 5 to 10 days of treatment, the total effective rate of the control group was significantly lower than that of the experimental group. The cough disappearing time, pulmonary rales disappearing time, and shortness of breath relief time were significantly longer than those in the experimental group (P <0.05 ). Conclusion Azithromycin combined with Mucosolvan treatment of children with mycoplasma pneumonia significantly improved the condition, it is widely used.